SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-025679
Filing Date
2022-09-13
Accepted
2022-09-13 07:00:39
Documents
38
Period of Report
2022-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39094
2 ex99-1.htm EX-99.1 24953
3 ex99-1_001.jpg GRAPHIC 34502
4 ex99-1_002.jpg GRAPHIC 139204
5 ex99-1_003.jpg GRAPHIC 82104
6 ex99-1_004.jpg GRAPHIC 88436
7 ex99-1_005.jpg GRAPHIC 101134
8 ex99-1_006.jpg GRAPHIC 76591
9 ex99-1_007.jpg GRAPHIC 98916
10 ex99-1_008.jpg GRAPHIC 91162
11 ex99-1_009.jpg GRAPHIC 37919
12 ex99-1_010.jpg GRAPHIC 63397
13 ex99-1_011.jpg GRAPHIC 83773
14 ex99-1_012.jpg GRAPHIC 99642
15 ex99-1_013.jpg GRAPHIC 102506
16 ex99-1_014.jpg GRAPHIC 99791
17 ex99-1_015.jpg GRAPHIC 95423
18 ex99-1_016.jpg GRAPHIC 78300
19 ex99-1_017.jpg GRAPHIC 107499
20 ex99-1_018.jpg GRAPHIC 38159
21 ex99-1_019.jpg GRAPHIC 112281
22 ex99-1_020.jpg GRAPHIC 72686
23 ex99-1_021.jpg GRAPHIC 87167
24 ex99-1_022.jpg GRAPHIC 62226
25 ex99-1_023.jpg GRAPHIC 87789
26 ex99-1_024.jpg GRAPHIC 96434
27 ex99-1_025.jpg GRAPHIC 42096
  Complete submission text file 0001493152-22-025679.txt   3107170

Data Files

Seq Description Document Type Size
28 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mtnb-20220913.xsd EX-101.SCH 3251
29 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mtnb-20220913_lab.xml EX-101.LAB 34916
30 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mtnb-20220913_pre.xml EX-101.PRE 22805
32 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3760
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 221239720
SIC: 2834 Pharmaceutical Preparations